SEC Stock Data Quick Answer Xerox Holdings Corp reported Cash and Equivalents of $512.00 million for fiscal year 2025. Xerox Holdings Corp Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $512.00M -11.1% 2024 $576.00M +11.0% 2023 $519.00M -50.3% 2022 $1.04B -43.2% 2021 $1.84B -29.9% 2020 $2.62B -4.2% 2019 $2.74B +153.5% 2018 $1.08B … Read more
Quick Answer Xerox Holdings Corp reported Total Assets of $9.82 billion for fiscal year 2025. Xerox Holdings Corp Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $9.82B +17.4% 2024 $8.37B -16.4% 2023 $10.01B -13.3% 2022 $11.54B -12.7% 2021 $13.22B -10.3% 2020 $14.74B -2.0% 2019 $15.05B +1.2% 2018 $14.87B — Quarterly Total … Read more
Quick Answer Xerox Holdings Corp reported Diluted EPS of $8.25 per share (loss) for fiscal year 2025. Xerox Holdings Corp Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$8.25 +23.3% 2024 -$10.75 -11844.4% 2023 -$0.09 +95.8% 2022 -$2.15 +16.0% 2021 -$2.56 -404.8% 2020 $0.84 -85.5% 2019 $5.80 +320.3% 2018 $1.38 +94.4% … Read more
Quick Answer Xerox Holdings Corp reported Net Income of -$1.03 billion for fiscal year 2025. Xerox Holdings Corp Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$1.03B +22.1% 2024 -$1.32B -132200.0% 2023 $1.00M +100.3% 2022 -$322.00M +29.2% 2021 -$455.00M -337.0% 2020 $192.00M -85.8% 2019 $1.35B +274.8% 2018 $361.00M +85.1% 2017 $195.00M … Read more
Quick Answer Xerox Holdings Corp reported Revenue (ASC 606) of $7.02 billion for fiscal year 2025. Xerox Holdings Corp Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $7.02B +12.9% 2024 $6.22B -9.7% 2023 $6.89B -3.1% 2022 $7.11B +1.0% 2021 $7.04B +0.2% 2020 $7.02B -22.5% 2019 $9.07B -6.2% 2018 $9.66B … Read more
Quick Answer Xerox Holdings Corp reported Total Revenue of $7.02 billion for fiscal year 2025. Xerox Holdings Corp Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $7.02B +12.9% 2024 $6.22B -9.7% 2023 $6.89B -3.1% 2022 $7.11B +1.0% 2021 $7.04B +0.2% 2020 $7.02B -22.5% 2019 $9.07B +7648.7% 2018 $117.00M -98.8% 2017 $9.99B … Read more
Quick Answer Xerox Holdings Corp reported Total Revenue of $7.02 billion for fiscal year 2025. Xerox Holdings Corp — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $7.02B+12.9% $6.22B-9.7% $6.89B-3.1% $7.11B+1.0% $7.04B+0.2% $7.02B-22.5% Revenue (ASC 606) $7.02B+12.9% $6.22B-9.7% $6.89B-3.1% $7.11B+1.0% $7.04B+0.2% $7.02B-22.5% Net Income -$1.03B+22.1% -$1.32B-132200.0% $1.00M+100.3% -$322.00M+29.2% -$455.00M-337.0% $192.00M-85.8% … Read more
Quick Answer XORTX Therapeutics Inc. reported R&D Expense of $574.9 thousand for fiscal year 2025. XORTX Therapeutics Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $574.9K +212.8% 2024 $183.8K -92.4% 2023 $2.42M -64.2% 2022 $6.76M +897.9% 2021 $677.6K +144.2% 2020 $277.5K +595.4% 2019 $39.9K — XORTX Therapeutics Inc. showed an … Read more
Quick Answer XORTX Therapeutics Inc. reported Total Assets of $2.68 million for fiscal year 2025. XORTX Therapeutics Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $2.68M -34.5% 2024 $4.09M -25.1% 2023 $5.47M -55.8% 2022 $12.37M -28.8% 2021 $17.38M +658.9% 2020 $2.29M — XORTX Therapeutics Inc. showed a decrease of -34.5% … Read more
Quick Answer XORTX Therapeutics Inc. reported Total Assets of $2.68 million for fiscal year 2025. XORTX Therapeutics Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Assets $2.68M-34.5% $4.09M-25.1% $5.47M-55.8% $12.37M-28.8% $17.38M+658.9% $2.29M R&D Expense $574.9K+212.8% $183.8K-92.4% $2.42M-64.2% $6.76M+897.9% $677.6K+144.2% $277.5K+595.4% XORTX Therapeutics Inc. reported Total Assets of $2.68 million … Read more